Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2010
(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1
and 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Charenton-le-Pont, France (November 4, 2010 - 06:00 pm) - As of October 31,
2010, shares and voting rights outstanding of Essilor, the world leader in
ophthalmic optics, broke down as follows:
October 31, 2010
Shares outstanding 213,239,012
Exercisable voting rights 227,325,953
Total potential voting rights, including
rights attached to shares held in treasury
and under the liquidity contract. 231,587,369
The world leader in ophthalmic optical products, Essilor International
researches, develops, manufactures and markets around the world a wide range of
lenses to correct myopia, hyperopia, presbyopia and astigmatism. Its flagship
brands are Varilux(r), Crizal(r), Essilor(r), Definity(r) and Xperio(TM).
Based in France, the company reported consolidated revenue of EUR3.2 billion in
2009, with 34,700 employees and operations in 100 countries.
For more information, please visit www.essilor.com.
The Essilor share trades on the NYSE Euronext Paris market and is included in
the CAC 40 index. Codes and symbols: ISIN: FR FR0000121667; Reuters: ESSI.PA;